Patents by Inventor Yinyong ZHANG

Yinyong ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11840517
    Abstract: Provided herein are a lappaconitine derivative of formula (I), and a preparation and application thereof.
    Type: Grant
    Filed: January 22, 2022
    Date of Patent: December 12, 2023
    Assignee: Southwest Jiaotong University
    Inventors: Xianli Zhou, Feng Gao, Xiaohuan Li, Yuzhu Li, Shuai Huang, Lin Chen, Yinyong Zhang
  • Publication number: 20220144779
    Abstract: Provided herein are a lappaconitine derivative of formula (I), and a preparation and application thereof.
    Type: Application
    Filed: January 22, 2022
    Publication date: May 12, 2022
    Inventors: Xianli ZHOU, Feng GAO, Xiaohuan LI, Yuzhu LI, Shuai HUANG, Lin CHEN, Yinyong ZHANG
  • Patent number: 11180509
    Abstract: Disclosed in the present invention are a thiazolidone spiro pyrimidine trione compound, a preparation method therefor and uses thereof, the compound having a structure represented by formula (I). In the formula, the definitions of the substituents are described in the specification and the claims. The thiazolidone spiro pyrimidine trione compound in the present invention has high in vivo and in vitro antibacterial activity, has better metabolic properties, and is obviously superior to existing compounds of the same kind.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: November 23, 2021
    Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Yushe Yang, Yinyong Zhang, Chenghui Shi, Qian Chen
  • Publication number: 20210079019
    Abstract: Disclosed in the present invention are a thiazolidone spiro pyrimidine trione compound, a preparation method therefor and uses thereof, the compound having a structure represented by formula (I). In the formula, the definitions of the substituents are described in the specification and the claims. The thiazolidone spiro pyrimidine trione compound in the present invention has high in vivo and in vitro antibacterial activity, has better metabolic properties, and is obviously superior to existing compounds of the same kind.
    Type: Application
    Filed: June 21, 2018
    Publication date: March 18, 2021
    Inventors: Yushe YANG, Yinyong ZHANG, Chenghui SHI, Qian CHEN